Oxycodone Self-administration Activates the Mitogen-activated Protein Kinase/ Mitogen- and Stress-activated Protein Kinase (MAPK-MSK) Signaling Pathway in the Rat Dorsal Striatum

Overview

Journal Sci Rep

Specialty Science

Date 2021 Jan 29

PMID 33510349

Citations 8

Authors

Christopher A Blackwood

Michael T McCoy

Bruce Ladenheim

Jean Lud Cadet

Affiliations

Soon will be listed here.

Abstract

To identify signaling pathways activated by oxycodone self-administration (SA), Sprague-Dawley rats self-administered oxycodone for 20 days using short-(ShA, 3 h) and long-access (LgA, 9 h) paradigms. Animals were euthanized 2 h after SA cessation and dorsal striata were used in post-mortem molecular analyses. LgA rats escalated their oxycodone intake and separated into lower (LgA-L) or higher (LgA-H) oxycodone takers. LgA-H rats showed increased striatal protein phosphorylation of ERK1/2 and MSK1/2. Histone H3, phosphorylated at serine 10 and acetylated at lysine 14 (H3S10pK14Ac), a MSK1/2 target, showed increased abundance only in LgA-H rats. RT-qPCR analyses revealed increased AMPA receptor subunits, GluA2 and GluA3 mRNAs, in the LgA-H rats. GluA3, but not GluA2, mRNA expression correlated positively with changes in pMSK1/2 and H3S10pK14Ac. These findings suggest that escalated oxycodone SA results in MSK1/2-dependent histone phosphorylation and increases in striatal gene expression. These observations offer potential avenues for interventions against oxycodone addiction.

Citing Articles

Substance-Induced Psychiatric Disorders, Epigenetic and Microbiome Alterations, and Potential for Therapeutic Interventions.

Nohesara S, Mostafavi Abdolmaleky H, Thiagalingam S Brain Sci. 2024; 14(8).

PMID: 39199463 PMC: 11352452. DOI: 10.3390/brainsci14080769.

Neuroplasticity-related genes correlate with individual differences in distinct phases of oxycodone self-administration in male rats.

Vassoler F, Budge K, Isgate S, Gildawie K, Byrnes E Neuropharmacology. 2024; 254:109972.

PMID: 38710443 PMC: 11164234. DOI: 10.1016/j.neuropharm.2024.109972.

Oxycodone, an opioid like the others?.

Marie N, Noble F Front Psychiatry. 2023; 14:1229439.

PMID: 38152360 PMC: 10751306. DOI: 10.3389/fpsyt.2023.1229439.

Uncovering novel regulators of memory using C. elegans genetic and genomic analysis.

Brandel-Ankrapp K, Arey R Biochem Soc Trans. 2023; 51(1):161-171.

PMID: 36744642 PMC: 10518207. DOI: 10.1042/BST20220455.

GluA2-lacking AMPA receptors in the nucleus accumbens core and shell contribute to the incubation of oxycodone craving in male rats.

Wong B, Zimbelman A, Milovanovic M, Wolf M, Stefanik M Addict Biol. 2022; 27(6):e13237.

PMID: 36301206 PMC: 10655598. DOI: 10.1111/adb.13237.

References

Cicero T, Inciardi J, Munoz A . Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain. 2005; 6(10):662-72. DOI: 10.1016/j.jpain.2005.05.004. View

Skolnick P . The Opioid Epidemic: Crisis and Solutions. Annu Rev Pharmacol Toxicol. 2017; 58:143-159. DOI: 10.1146/annurev-pharmtox-010617-052534. View

Balyan R, Hahn D, Huang H, Chidambaran V . Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic. Expert Opin Drug Metab Toxicol. 2020; 16(2):125-141. PMC: 7199505. DOI: 10.1080/17425255.2020.1721458. View

Gaskell H, Derry S, Stannard C, Moore R . Oxycodone for neuropathic pain in adults. Cochrane Database Syst Rev. 2016; 7:CD010692. PMC: 6457997. DOI: 10.1002/14651858.CD010692.pub3. View

Schmidt-Hansen M, Bennett M, Arnold S, Bromham N, Hilgart J . Oxycodone for cancer-related pain. Cochrane Database Syst Rev. 2017; 8:CD003870. PMC: 6421939. DOI: 10.1002/14651858.CD003870.pub6. View

Van Zee A . The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2008; 99(2):221-7. PMC: 2622774. DOI: 10.2105/AJPH.2007.131714. View

Rudd R, Seth P, David F, Scholl L . Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016; 65(50-51):1445-1452. DOI: 10.15585/mmwr.mm655051e1. View

Seth P, Scholl L, Rudd R, Bacon S . Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018; 67(12):349-358. PMC: 5877356. DOI: 10.15585/mmwr.mm6712a1. View

Schuckit M . Treatment of Opioid-Use Disorders. N Engl J Med. 2016; 375(4):357-68. DOI: 10.1056/NEJMra1604339. View

10.

Cadet J, Bisagno V . Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches. Front Psychiatry. 2016; 6:189. PMC: 4713863. DOI: 10.3389/fpsyt.2015.00189. View

11.

Cadet J, Bisagno V, Milroy C . Neuropathology of substance use disorders. Acta Neuropathol. 2013; 127(1):91-107. PMC: 7453825. DOI: 10.1007/s00401-013-1221-7. View

12.

Noble F, Lenoir M, Marie N . The opioid receptors as targets for drug abuse medication. Br J Pharmacol. 2015; 172(16):3964-79. PMC: 4543606. DOI: 10.1111/bph.13190. View

13.

Stein C . Opioid Receptors. Annu Rev Med. 2015; 67:433-51. DOI: 10.1146/annurev-med-062613-093100. View

14.

Ehrich J, Messinger D, Knakal C, Kuhar J, Schattauer S, Bruchas M . Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons. J Neurosci. 2015; 35(37):12917-31. PMC: 4571610. DOI: 10.1523/JNEUROSCI.2444-15.2015. View

15.

Schulz R, Eisinger D, Wehmeyer A . Opioid control of MAP kinase cascade. Eur J Pharmacol. 2004; 500(1-3):487-97. DOI: 10.1016/j.ejphar.2004.07.010. View

16.

Wagley Y, Law P, Wei L, Loh H . Epigenetic Activation of -Opioid Receptor Gene via Increased Expression and Function of Mitogen- and Stress-Activated Protein Kinase 1. Mol Pharmacol. 2017; 91(4):357-372. PMC: 5363709. DOI: 10.1124/mol.116.106567. View

17.

Al-Hasani R, Bruchas M . Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011; 115(6):1363-81. PMC: 3698859. DOI: 10.1097/ALN.0b013e318238bba6. View

18.

Bruchas M, Roth B . New Technologies for Elucidating Opioid Receptor Function. Trends Pharmacol Sci. 2016; 37(4):279-289. PMC: 4811714. DOI: 10.1016/j.tips.2016.01.001. View

19.

Blackwood C, Hoerle R, Leary M, Schroeder J, Job M, McCoy M . Molecular Adaptations in the Rat Dorsal Striatum and Hippocampus Following Abstinence-Induced Incubation of Drug Seeking After Escalated Oxycodone Self-Administration. Mol Neurobiol. 2018; 56(5):3603-3615. PMC: 6477015. DOI: 10.1007/s12035-018-1318-z. View

20.

Blackwood C, Leary M, Salisbury A, McCoy M, Cadet J . Escalated Oxycodone Self-Administration Causes Differential Striatal mRNA Expression of FGFs and IEGs Following Abstinence-Associated Incubation of Oxycodone Craving. Neuroscience. 2019; 415:173-183. PMC: 7448685. DOI: 10.1016/j.neuroscience.2019.07.030. View